{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:02:57Z","timestamp":1778004177202,"version":"3.51.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:00:00Z","timestamp":1318550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00018-011-0837-9","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T04:14:06Z","timestamp":1318479246000},"page":"41-48","source":"Crossref","is-referenced-by-count":87,"title":["Inflammatory bowel disease: is it a primary immunodeficiency?"],"prefix":"10.1007","volume":"69","author":[{"given":"Erik","family":"Glocker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,14]]},"reference":[{"key":"837_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417\u2013429","journal-title":"N Engl J Med"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627\u20131640","journal-title":"Lancet"},{"key":"837_CR3","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1542\/peds.2008-2306","volume":"122","author":"C Romano","year":"2008","unstructured":"Romano C, Famiani A, Gallizzi R et al (2008) Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children. Pediatrics 122:e1278\u2013e1281","journal-title":"Pediatrics"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427\u2013434","journal-title":"Nature"},{"issue":"Suppl 5","key":"837_CR5","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1136\/gut.2004.043372","volume":"53","author":"MJ Carter","year":"2004","unstructured":"Carter MJ, Lobo AJ (2004) Travis SP; IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 53(Suppl 5):V1\u2013V16","journal-title":"Gut"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00535-010-0219-3","volume":"45","author":"MA Engel","year":"2010","unstructured":"Engel MA, Neurath MF (2010) New pathophysiological insights and modern treatment of IBD. J Gastroenterol 45:571\u2013583","journal-title":"J Gastroenterol"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.187.4.571","volume":"187","author":"SD Spencer","year":"1998","unstructured":"Spencer SD, Di Marco F, Hooley J et al (1998) The orphan receptor CRF2\u20134 is an essential subunit of the interleukin 10 receptor. J Exp Med 187:571\u2013578","journal-title":"J Exp Med"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-007-2111-3","volume":"43","author":"A Mizoguchi","year":"2008","unstructured":"Mizoguchi A, Mizoguchi E (2008) Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 43:1\u201317","journal-title":"J Gastroenterol"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.0105-2896.2005.00291.x","volume":"206","author":"CO Elson","year":"2005","unstructured":"Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT (2005) Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260\u2013276","journal-title":"Immunol Rev"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ajcn\/30.11.1819","volume":"30","author":"AB Onderdonk","year":"1977","unstructured":"Onderdonk AB, Hermos JA, Bartlett JG (1977) The role of the intestinal microflora in experimental colitis. Am J Clin Nutr 30:1819\u20131825","journal-title":"Am J Clin Nutr"},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2009.08.011","volume":"31","author":"M Barnes","year":"2009","unstructured":"Barnes M, Powrie F (2009) Regulatory T cells reinforce intestinal homeostasis. Immunity 31:401\u2013411","journal-title":"Immunity"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nri2316","volume":"8","author":"D Artis","year":"2008","unstructured":"Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8:411\u2013420","journal-title":"Nat Rev Immunol"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MOG.0b013e328311f26e","volume":"24","author":"EK Boden","year":"2008","unstructured":"Boden EK, Snapper SB (2008) Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 24:733\u2013741","journal-title":"Curr Opin Gastroenterol"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4:330\u2013336","journal-title":"Nat Immunol"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579\u2013591","journal-title":"Immunity"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr, Muller W, Rudensky AY (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546\u2013558","journal-title":"Immunity"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nri2340","volume":"8","author":"JH Cho","year":"2008","unstructured":"Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458\u2013466","journal-title":"Nat Rev Immunol"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-genom-082908-150013","volume":"10","author":"J Limbergen Van","year":"2009","unstructured":"Van Limbergen J, Wilson DC, Satsangi J (2009) The genetics of Crohn\u2019s disease. Annu Rev Genomics Hum Genet 10:89\u2013116","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"837_CR19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease. Nat Genet 40:955\u2013962","journal-title":"Nat Genet"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","volume":"39","author":"J Hampe","year":"2007","unstructured":"Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207\u2013211","journal-title":"Nat Genet"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng2061","volume":"39","author":"M Parkes","year":"2007","unstructured":"Parkes M, Barrett JC, Prescott NJ et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn\u2019s disease susceptibility. Nat Genet 39:830\u2013832","journal-title":"Nat Genet"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature07416","volume":"456","author":"K Cadwell","year":"2008","unstructured":"Cadwell K, Liu JY, Brown SL et al (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259\u2013263","journal-title":"Nature"},{"key":"837_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411:599\u2013603","journal-title":"Nature"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1572-0241.2004.40304.x","volume":"99","author":"M Economou","year":"2004","unstructured":"Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn\u2019s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393\u20132404","journal-title":"Am J Gastroenterol"},{"key":"837_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MIB.0000195389.11645.ab","volume":"12","author":"M Pierik","year":"2006","unstructured":"Pierik M, Joossens S, Van Steen K et al (2006) Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12:1\u20138","journal-title":"Inflamm Bowel Dis"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/ddh090","volume":"13","author":"DA Heel van","year":"2004","unstructured":"van Heel DA, Fisher SA, Kirby A et al (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13:763\u2013770","journal-title":"Hum Mol Genet"},{"key":"837_CR27","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461\u20131463","journal-title":"Science"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"e819","DOI":"10.1371\/journal.pone.0000819","volume":"2","author":"J Glas","year":"2007","unstructured":"Glas J, Seiderer J, Wetzke M et al (2007) rs1004819 is the main disease-associated IL23R variant in German Crohn\u2019s disease patients: combined analysis of IL23R, CARD15, and OCTN1\/2 variants. PLoS One 2:e819","journal-title":"PLoS One"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ng.145","volume":"40","author":"SA Fisher","year":"2008","unstructured":"Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn\u2019s disease. Nat Genet 40:710\u2013712","journal-title":"Nat Genet"},{"key":"837_CR30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/ibd.20478","volume":"14","author":"KD Taylor","year":"2008","unstructured":"Taylor KD, Targan SR, Mei L et al (2008) IL23R haplotypes provide a large population attributable risk for Crohn\u2019s disease. Inflamm Bowel Dis 14:1185\u20131191","journal-title":"Inflamm Bowel Dis"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ng1345","volume":"36","author":"M Stoll","year":"2004","unstructured":"Stoll M, Corneliussen B, Costello CM et al (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36:476\u2013480","journal-title":"Nat Genet"},{"key":"837_CR32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cell.2008.07.021","volume":"134","author":"A Kaser","year":"2008","unstructured":"Kaser A, Lee AH, Franke A et al (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134:743\u2013756","journal-title":"Cell"},{"key":"837_CR33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ajhg.2008.03.016","volume":"82","author":"A Zhernakova","year":"2008","unstructured":"Zhernakova A, Festen EM, Franke L et al (2008) Genetic analysis of innate immunity in Crohn\u2019s disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 82:1202\u20131210","journal-title":"Am J Hum Genet"},{"key":"837_CR34","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","volume":"361","author":"EO Glocker","year":"2009","unstructured":"Glocker EO, Kotlarz D, Boztug K et al (2009) Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361:2033\u20132045","journal-title":"N Engl J Med"},{"key":"837_CR35","unstructured":"Glocker EO, Frede N, Perro M, et al. Severe early-onset colitis due to a mutation in interleukin-10. The Lancet (accepted)"},{"key":"837_CR36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0049-0172(98)80002-4","volume":"27","author":"IO Akman","year":"1998","unstructured":"Akman IO, Ostrov BE, Neudorf S (1998) Autoimmune manifestations of the Wiskott\u2013Aldrich syndrome. Semin Arthritis Rheum 27:218\u2013225","journal-title":"Semin Arthritis Rheum"},{"key":"837_CR37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.2291","volume":"214","author":"DJB Marks","year":"2008","unstructured":"Marks DJB, Segal AW (2008) Innate immunity in inflammatory bowel disease: a disease hypothesis. J Pathol 214:260\u2013266","journal-title":"J Pathol"},{"key":"837_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ajg.2008.72","volume":"104","author":"DJB Marks","year":"2009","unstructured":"Marks DJB, Miyagi K, Rahman FZ et al (2009) Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn\u2019s disease. Am J Gastroenterol 104:117\u2013124","journal-title":"Am J Gastroenterol"},{"key":"837_CR39","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/ibd.20449","volume":"14","author":"FZ Rahman","year":"2008","unstructured":"Rahman FZ, Marks DJB, Hayee BH et al (2008) Phagocytic dysfunction and inflammatory bowel disease. Inflamm Bowel Dis 14:1443\u20131452","journal-title":"Inflamm Bowel Dis"},{"key":"837_CR40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"G Bouma","year":"2003","unstructured":"Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521\u2013533","journal-title":"Nat Rev Immunol"},{"key":"837_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(76)91024-2","volume":"308","author":"AW Segal","year":"1976","unstructured":"Segal AW, Loewi G (1976) Neutrophil dysfunction in Crohn\u2019s disease. Lancet 308:219\u2013221","journal-title":"Lancet"},{"key":"837_CR42","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(06)68265-2","volume":"367","author":"DJB Marks","year":"2006","unstructured":"Marks DJB, Harbord MWN, MacAllister R et al (2006) Defective acute inflammation in Crohn\u2019s disease: a clinical investigation. Lancet 367:668\u2013678","journal-title":"Lancet"},{"key":"837_CR43","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20091233","volume":"206","author":"AM Smith","year":"2009","unstructured":"Smith AM, Rahman FZ, Hayee BH et al (2009) Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn\u2019s disease. J Exp Med 206:1883\u20131897","journal-title":"J Exp Med"},{"key":"837_CR44","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1084\/jem.20091683","volume":"206","author":"JL Casanova","year":"2009","unstructured":"Casanova JL, Abel L (2009) Revisiting Crohn\u2019s disease as a primary immunodeficiency of macrophages. J Exp Med 206:1839\u20131843","journal-title":"J Exp Med"},{"key":"837_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.suc.2007.03.003","volume":"87","author":"K Ephgrave","year":"2007","unstructured":"Ephgrave K (2007) Extra-intestinal manifestations of Crohn\u2019s disease. Surg Clin North Am 87:673\u2013680","journal-title":"Surg Clin North Am"},{"key":"837_CR46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"837_CR47","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","volume":"174","author":"C Bogdan","year":"1991","unstructured":"Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549\u20131555","journal-title":"J Exp Med"},{"key":"837_CR48","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"R Waal Malefyt de","year":"1991","unstructured":"de Waal Malefyt R, Haanen J, Spits H et al (1991) Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174:915\u2013924","journal-title":"J Exp Med"},{"key":"837_CR49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2004.01988.x","volume":"113","author":"LM Williams","year":"2004","unstructured":"Williams LM, Ricchetti G, Sarma U et al (2004) Interleukin-10 suppression of myeloid cell activation\u2014a continuing puzzle. Immunology 113:281\u2013292","journal-title":"Immunology"},{"key":"837_CR50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R K\u00fchn","year":"1993","unstructured":"K\u00fchn R, Lohler J, Rennick D et al (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263\u2013274","journal-title":"Cell"},{"key":"837_CR51","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1172\/JCI118290","volume":"96","author":"DJ Berg","year":"1995","unstructured":"Berg DJ, K\u00fchn R, Rajewsky K et al (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339\u20132347","journal-title":"J Clin Invest"},{"key":"837_CR52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","volume":"40","author":"A Franke","year":"2008","unstructured":"Franke A, Balschun T, Karlsen TH et al (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319\u20131323","journal-title":"Nat Genet"},{"key":"837_CR53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/00365520310003011","volume":"38","author":"K Linde van der","year":"2003","unstructured":"van der Linde K, Boor PP, Sandkuijl LA et al (2003) A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease. Scand J Gastroenterol 38:611\u2013617","journal-title":"Scand J Gastroenterol"},{"key":"837_CR54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ni.1722","volume":"10","author":"E Noguchi","year":"2009","unstructured":"Noguchi E, Homma Y, Kang X et al (2009) A Crohn\u2019s disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 10:471\u2013479","journal-title":"Nat Immunol"},{"key":"837_CR55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.it.2003.10.007","volume":"24","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Hugot JP, Sansonetti PJ (2003) Lessons from Nod2 studies: towards a link between Crohn\u2019s disease and bacterial sensing. Trends Immunol 24:652\u2013658","journal-title":"Trends Immunol"},{"key":"837_CR56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u2013606","journal-title":"Nature"},{"key":"837_CR57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/107999099313695","volume":"19","author":"RP Donnelly","year":"1999","unstructured":"Donnelly RP, Dickensheets H, Finbloom DS (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19:563\u2013573","journal-title":"J Interferon Cytokine Res"},{"key":"837_CR58","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1093\/emboj\/16.19.5894","volume":"16","author":"SV Kotenko","year":"1997","unstructured":"Kotenko SV, Krause CD, Izotova LS et al (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. The EMBO J 16:5894\u20135903","journal-title":"The EMBO J"},{"key":"837_CR59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","volume":"28","author":"JJ O\u2019Shea","year":"2008","unstructured":"O\u2019Shea JJ, Murray PJ (2008) Cytokine signaling modules in inflammatory responses. Immunity 28:477\u2013487","journal-title":"Immunity"},{"key":"837_CR60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","volume":"172","author":"L Williams","year":"2004","unstructured":"Williams L, Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567\u2013576","journal-title":"J Immunol"},{"key":"837_CR61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","volume":"17","author":"K Wolk","year":"2006","unstructured":"Wolk K, Sabat R (2006) Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine & Growth Factor Rev 17:367\u2013380","journal-title":"Cytokine & Growth Factor Rev"},{"key":"837_CR62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaci.2008.02.026","volume":"121","author":"S Commins","year":"2008","unstructured":"Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108\u20131111","journal-title":"J Allergy Clin Immunol"},{"key":"837_CR63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1189\/jlb.0204117","volume":"76","author":"RP Donnelly","year":"2004","unstructured":"Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H (2004) The expanded family of class II cytokines that share the IL-10 receptor-2(IL-10R2) chain. J Leukoc Biol 76:314\u2013321","journal-title":"J Leukoc Biol"},{"key":"837_CR64","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Ogawa A, Mizoguchi E et al (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534\u2013544","journal-title":"J Clin Invest"},{"key":"837_CR65","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","volume":"29","author":"LA Zenewicz","year":"2008","unstructured":"Zenewicz LA, Yancopoulos GD, Valenzuela DM et al (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29:947\u2013957","journal-title":"Immunity"},{"key":"837_CR66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng Y, Valdez PA, Danilenko DM et al (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282\u2013289","journal-title":"Nat Med"},{"key":"837_CR67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241\u2013254","journal-title":"Immunity"},{"key":"837_CR68","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk K, Witte E, Wallace E, D\u00f6cke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309\u20131323","journal-title":"Eur J Immunol"},{"key":"837_CR69","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","volume":"8","author":"JK Kolls","year":"2008","unstructured":"Kolls JK, McCray PB Jr, Chan YR (2008) Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 8:829\u2013835","journal-title":"Nat Rev Immunol"},{"key":"837_CR70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV et al (2003) IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69\u201377","journal-title":"Nat Immunol"},{"key":"837_CR71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63\u201368","journal-title":"Nat Immunol"},{"key":"837_CR72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021345","volume":"197","author":"KJ Maloy","year":"2003","unstructured":"Maloy KJ, Salaun L, Cahill R et al (2003) CD4\u00a0+\u00a0CD25\u00a0+\u00a0T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111\u2013119","journal-title":"J Exp Med"},{"key":"837_CR73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read S, Malmstr\u00f6m V, Powrie F (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192:295\u2013302","journal-title":"J Exp Med"},{"key":"837_CR74","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","volume":"170","author":"C Mottet","year":"2003","unstructured":"Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4+ CD25+ regulatory T cells. J Immunol 170:3939\u20133943","journal-title":"J Immunol"},{"key":"837_CR75","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.1760","volume":"10","author":"M Feuerer","year":"2009","unstructured":"Feuerer M, Hill JA, Mathis D, Benoist C (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10:689\u2013695","journal-title":"Nat Immunol"},{"key":"837_CR76","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.immuni.2009.04.009","volume":"30","author":"SZ Josefowicz","year":"2009","unstructured":"Josefowicz SZ, Rudensky A (2009) Control of regulatory T cell lineage commitment and maintenance. Immunity 30:616\u2013625","journal-title":"Immunity"},{"key":"837_CR77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","volume":"28","author":"CW Lio","year":"2008","unstructured":"Lio CW, Hsieh CS (2008) A two-step process for thymic regulatory T cell development. Immunity 28:100\u2013111","journal-title":"Immunity"},{"key":"837_CR78","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","volume":"5","author":"F Powrie","year":"1993","unstructured":"Powrie F, Leach MW, Mauze S et al (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5:1461\u20131471","journal-title":"Int Immunol"},{"key":"837_CR79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/302761","volume":"66","author":"CL Bennett","year":"2000","unstructured":"Bennett CL, Yoshioka R, Kiyosawa H et al (2000) X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23\u2013Xq13.3. Am J Hum Genet 66:461\u2013468","journal-title":"Am J Hum Genet"},{"key":"837_CR80","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","volume":"100","author":"BR Powell","year":"1982","unstructured":"Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731\u2013737","journal-title":"J Pediatr"},{"key":"837_CR81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"SF Ziegler","year":"2006","unstructured":"Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24:209\u2013226","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"837_CR82","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","volume":"28","author":"D Moraes-Vasconcelos","year":"2008","unstructured":"Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD (2008) Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 28(Suppl 1):S11\u2013S19","journal-title":"J Clin Immunol"},{"key":"837_CR83","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","volume":"15","author":"E Gambineri","year":"2003","unstructured":"Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr Opin Rheumatol 15:430\u2013435","journal-title":"Curr Opin Rheumatol"},{"key":"837_CR84","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.140.4.466","volume":"140","author":"DS Nieves","year":"2004","unstructured":"Nieves DS, Phipps RP, Pollock SJ et al (2004) Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 140:466\u2013472","journal-title":"Arch Dermatol"},{"key":"837_CR85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaci.2007.08.044","volume":"120","author":"TR Torgerson","year":"2007","unstructured":"Torgerson TR, Ochs HD (2007) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 120:744\u2013750","journal-title":"J Allergy Clin Immunol"},{"key":"837_CR86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2350\/06-07-0130.1","volume":"10","author":"ML Heltzer","year":"2007","unstructured":"Heltzer ML, Choi JK, Ochs HD et al (2007) A potential screening tool for IPEX syndrome. Pediatr Dev Pathol 10:98\u2013105","journal-title":"Pediatr Dev Pathol"},{"key":"837_CR87","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008480-200112000-00007","volume":"13","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Ochs HD (2001) IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 13:533\u2013538","journal-title":"Curr Opin Pediatr"},{"key":"837_CR88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-3083.2008.02055.x","volume":"68","author":"BT Costa-Carvalho","year":"2008","unstructured":"Costa-Carvalho BT, de Moraes-Pinto MI, de Almeida LC et al (2008) A remarkable depletion of both na\u00efve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain. Scand J Immunol 68:85\u201391","journal-title":"Scand J Immunol"},{"key":"837_CR89","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","volume":"436","author":"N Watanabe","year":"2005","unstructured":"Watanabe N, Wang YH, Lee HK et al (2005) Hassall\u2019s corpuscles instruct dendritic cells to induce CD4+ CD25+ regulatory T cells in human thymus. Nature 436:1181\u20131185","journal-title":"Nature"},{"key":"837_CR90","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/gut.2006.095588","volume":"56","author":"JR Korzenik","year":"2007","unstructured":"Korzenik JR (2007) Is Crohn\u2019s disease due to defective immunity? Gut 56:2\u20135","journal-title":"Gut"},{"key":"837_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-4439(94)90100-7","volume":"1227","author":"AJ Thrasher","year":"1994","unstructured":"Thrasher AJ, Keep NH, Wientjes F, Segal AW (1994) Chronic granulomatous disease. Biochim Biophys Acta 1227:1\u201324","journal-title":"Biochim Biophys Acta"},{"key":"837_CR92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0968-0004(93)90051-N","volume":"18","author":"AW Segal","year":"1993","unstructured":"Segal AW, Abo A (1993) The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 18:43\u201347","journal-title":"Trends Biochem Sci"},{"key":"837_CR93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","volume":"23","author":"AW Segal","year":"2005","unstructured":"Segal AW (2005) How neutrophils kill microbes. Annu Rev Immunol 23:197\u2013223","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"837_CR94","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1080\/13693780902736620","volume":"47","author":"BH Segal","year":"2009","unstructured":"Segal BH, Romani LR (2009) Invasive aspergillosis in chronic granulomatous disease. Med Mycol 47(Suppl 1):S282\u2013S290","journal-title":"Med Mycol"},{"key":"837_CR95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00281-008-0121-8","volume":"30","author":"MJ Stasia","year":"2008","unstructured":"Stasia MJ, Li XJ (2008) Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 30:209\u2013235","journal-title":"Semin Immunopathol"},{"key":"837_CR96","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0016-5085(82)90023-3","volume":"82","author":"SL Werlin","year":"1982","unstructured":"Werlin SL, Chusid MJ, Caya J, Oechler HW (1982) Colitis in chronic granulomatous disease. Gastroenterology 82:328\u2013331","journal-title":"Gastroenterology"},{"key":"837_CR97","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","volume":"114","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Rosenzweig SD, Kleiner DE et al (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114:462\u2013468","journal-title":"Pediatrics"},{"key":"837_CR98","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20091245","volume":"207","author":"LS Westerberg","year":"2010","unstructured":"Westerberg LS, Meelu P, Baptista M et al (2010) Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J Exp Med 207:1145\u20131152","journal-title":"J Exp Med"},{"key":"837_CR99","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher AJ, Burns SO (2010) WASP: a key immunological multitasker. Nat Rev Immunol 10:182\u2013192","journal-title":"Nat Rev Immunol"},{"key":"837_CR100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0092-8674(00)81050-8","volume":"84","author":"M Symons","year":"1996","unstructured":"Symons M, Derry JM, Karlak B et al (1996) Wiskott\u2013Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723\u2013734","journal-title":"Cell"},{"key":"837_CR101","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35010008","volume":"404","author":"L Blanchoin","year":"2000","unstructured":"Blanchoin L, Amann KJ, Higgs HN et al (2000) Direct observation of dendritic actin filament networks nucleated by Arp2\/3 complex and WASP\/Scar proteins. Nature 404:1007\u20131011","journal-title":"Nature"},{"key":"837_CR102","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","volume":"117","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Thrasher AJ (2006) The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117:725\u2013738","journal-title":"J Allergy Clin Immunol"},{"key":"837_CR103","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ng0495-414","volume":"9","author":"A Villa","year":"1995","unstructured":"Villa A, Notarangelo L, Macchi P et al (1995) X-linked thrombocytopenia and Wiskott\u2013Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9:414\u2013417","journal-title":"Nat Genet"},{"key":"837_CR104","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1182\/blood.V99.6.2268","volume":"99","author":"LD Notarangelo","year":"2002","unstructured":"Notarangelo LD, Mazza C, Giliani S et al (2002) Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood 99:2268\u20132269","journal-title":"Blood"},{"key":"837_CR105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","volume":"27","author":"K Devriendt","year":"2001","unstructured":"Devriendt K, Kim AS, Mathijs G et al (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27:313\u2013317","journal-title":"Nat Genet"},{"key":"837_CR106","first-page":"212","volume":"68","author":"A Wiskott","year":"1937","unstructured":"Wiskott A (1937) Familiarer, angeborener Morbus Werlhofii? Monastsschr Kinderheilkd 68:212\u2013216","journal-title":"Monastsschr Kinderheilkd"},{"key":"837_CR107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.13.2.133","volume":"13","author":"RA Aldrich","year":"1954","unstructured":"Aldrich RA, Steinberg AG, Campbell DC (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13:133\u2013139","journal-title":"Pediatrics"},{"key":"837_CR108","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876\u2013885","journal-title":"J Pediatr"},{"key":"837_CR109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00431-008-0721-2","volume":"168","author":"Z Cannioto","year":"2009","unstructured":"Cannioto Z, Berti I, Martelossi S et al (2009) IBD and IBD mimicking enterocolitis in children younger than 2\u00a0years of age. Eur J Pediatr 168:149\u2013155","journal-title":"Eur J Pediatr"},{"issue":"5 Pt 1","key":"837_CR110","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","volume":"111","author":"S Dupuis-Girod","year":"2003","unstructured":"Dupuis-Girod S, Medioni J, Haddad E et al (2003) Autoimmunity in Wiskott\u2013Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111(5 Pt 1):e622\u2013e627","journal-title":"Pediatrics"},{"key":"837_CR111","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10875-009-9349-x","volume":"30","author":"J Rohr","year":"2010","unstructured":"Rohr J, Pannicke U, D\u00f6ring M et al (2010) Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency. J Clin Immunol 30:314\u2013320","journal-title":"J Clin Immunol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-011-0837-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-011-0837-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-011-0837-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:19:58Z","timestamp":1686399598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-011-0837-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,14]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1007\/s00018-011-0837-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,14]]}}}